Manjaro Weight loss injections: how the treatment actually works

Step 1 — Clinical assessment before anything is dispensed

The first thing to understand about tirzepatide is that the injection itself is only part of the story. Before a single pen is dispensed, a GPhC-registered Independent Prescriber reads your consultation (your medical history, current medicines, BMI, and any weight-related conditions) and decides whether the treatment is appropriate for you. A real clinician does this review, not automated software. At nume, that review happens the same day you submit your consultation.

Licensed eligibility under the Mounjaro UK SmPC covers adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol or obstructive sleep apnoea. Lower thresholds can apply for some ethnic backgrounds under NICE guidance TA1026. BMI alone does not guarantee approval; the prescriber weighs the whole picture. If you want to explore whether you might be eligible, starting a free consultation is the practical next step.

Once approved, identity is verified, weight is confirmed on a live video call, and the prescription is issued. For context on how the cost of private treatment compares across providers, the how much are weight loss injections page sets out what UK pricing typically includes.

Step 2, What arrives, and how to store it

Each Mounjaro KwikPen contains four weekly doses in a single pre-filled device. When your order is dispatched, it travels in plain, unbranded packaging via DPD; you can follow it on your phone with a live tracking link, and it arrives the next working day in a refrigerated state ready to use.

Storage matters. Tirzepatide must be kept refrigerated between 2°C and 8°C until you are ready to inject. There is a limited window during which the pen can be kept at room temperature, the exact duration is specified in the Patient Information Leaflet inside every box, and you should follow that, not a general figure from a website. Never freeze the pen, and keep it away from direct light.

Before each injection you will also need a fresh needle. Reusing needles blunts the tip and can cause unnecessary discomfort or skin reactions; the needle replacement packs stocked at our pharmacy are compatible with the KwikPen. Clean the injection site with an alcohol swab, let the skin dry for a few seconds, then inject at a 90-degree angle into the fatty tissue. Rotate the site each week, for example, left abdomen one week, right thigh the next.

Step 3, Dose titration and what to expect as treatment progresses

The dose schedule for tirzepatide runs through six strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. Treatment starts at 2.5 mg because the first pen's job is to let your body adjust to the medicine, not to produce the full therapeutic effect straight away. Gastrointestinal side effects (nausea, loose stools, indigestion) are most noticeable in the first days after starting or after a dose increase, and for most people they settle within one to two weeks.

Your prescriber decides the pace of titration based on how you are tolerating the current dose. The NHS tirzepatide page gives a clear patient-level overview of the medicine. Do not adjust your own dose or timing without prescriber guidance; that conversation belongs in your clinical review, not in general reading.

In the SURMOUNT-1 trial (involving over 2,500 adults with obesity and no diabetes across 72 weeks) participants on the 15 mg dose achieved an average body-weight reduction of around 20 to 21%. That figure is a trial average; individual results vary. For a fuller picture of how the evidence stacks up across tirzepatide and other options, including manjaros weight loss injection, the weight loss injections overview sets out results across the licensed options side by side.

Step 4 (Ongoing clinical oversight and when to seek help

Every repeat order at a regulated pharmacy should include a clinical review) not a rubber stamp. At nume, the prescriber checks your progress and current health before each repeat is approved. There are no subscriptions and no automatic renewals; each order is individually assessed.

Know the signs that need prompt medical attention. Severe, persistent stomach pain that spreads to the back (with or without vomiting) may indicate pancreatitis, which is a known but infrequent side effect of GLP-1 medicines; seek urgent help rather than waiting. Symptoms of dehydration from prolonged nausea or vomiting, signs of an allergic reaction, or significant changes in mood should also prompt a call to a doctor or 111. You can report suspected side effects directly to the MHRA via the Yellow Card scheme.

Women using oral contraceptive pills should be aware that during the first four weeks of tirzepatide and for four weeks after each dose increase, the pill's absorption may be reduced; adding a non-oral method during those periods is the current clinical advice. Discuss any concerns with your prescriber. Tirzepatide is not recommended during pregnancy, while breastfeeding, or for anyone trying to conceive, and it is not licensed for use in people under 18. Our FAQs page addresses several of the most common practical questions, including comparisons with the daily weight loss injection, the monjaro weight loss injection, and how tirzepatide fits among the 3 weight loss injections currently available in the UK. If you have concerns between orders, the contact page connects you to aftercare seven days a week.